Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma

Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinomaMetabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma, Published online: 31 October 2018; doi:10.1038/s41416-018-0242-3Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma

Source: British Journal of Cancer - October 31, 2018 Category: Cancer & Oncology Authors: Nada M. S. Al-Saffar Helen Troy Anne-Christine Wong Te Fong Roberta Paravati L. Elizabeth Jackson Sharon Gowan Jessica K. R. Boult Simon P. Robinson Suzanne A. Eccles Timothy A. Yap Martin O. Leach Yuen-Li Chung Source Type: research